MONGE, CHIARA
MONGE, CHIARA
SCIENZA E TECNOLOGIA DEL FARMACO
Beyond oncological hyperthermia: Physically drivable magnetic nanobubbles as novel multipurpose theranostic carriers in the central nervous system
2020-01-01 Ficiara E.; Ansari S.A.; Argenziano M.; Cangemi L.; Monge C.; Cavalli R.; D'Agata F.
Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas
2024-01-01 Dianzani, Chiara; Bozza, Annalisa; Bordano, Valentina; Cangemi, Luigi; Ferraris, Chiara; Foglietta, Federica; Monge, Chiara; Gallicchio, Margherita; Pizzimenti, Stefania; Marini, Elisabetta; Muntoni, Elisabetta; Valsania, Maria Carmen; Battaglia, Luigi
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma
2024-01-01 Blua F.; Monge C.; Gastaldi S.; Clemente N.; Pizzimenti S.; Lazzarato L.; Senetta R.; Vittorio S.; Gigliotti C.L.; Boggio E.; Dianzani U.; Vistoli G.; Altomare A.A.; Aldini G.; Dianzani C.; Marini E.; Bertinaria M.
Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications
2023-01-01 Boggio E.; Gigliotti C.L.; Stoppa I.; Pantham D.; Sacchetti S.; Rolla R.; Grattarola M.; Monge C.; Pizzimenti S.; Dianzani U.; Dianzani C.; Battaglia L.
G protein–coupled receptor 21 in macrophages: An in vitro study
2022-01-01 Bordano V.; Kinsella G.K.; Cannito S.; Dianzani C.; Gigliotti C.L.; Stephens J.C.; Monge C.; Bocca C.; Rosa A.C.; Miglio G.; Dianzani U.; Findlay J.B.C.; Benetti E.
Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases
2024-01-01 Bozza, Annalisa; Bordano, Valentina; Marengo, Arianna; Muntoni, Elisabetta; Marini, Elisabetta; Lazzarato, Loretta; Dianzani, Chiara; Monge, Chiara; Rosa, Arianna Carolina; Cangemi, Luigi; Valsania, Maria Carmen; Colitti, Barbara; Camisassa, Ezio; Battaglia, Luigi
ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis
2022-01-01 Alves, Gustavo Ferreira; Stoppa, Ian; Aimaretti, Eleonora; Monge, Chiara; Mastrocola, Raffaella; Porchietto, Elisa; Einaudi, Giacomo; Collotta, Debora; Bertocchi, Ilaria; Boggio, Elena; Gigliotti, Casimiro Luca; Clemente, Nausicaa; Aragno, Manuela; Fernandes, Daniel; Cifani, Carlo; Thiemermann, Christoph; Dianzani, Chiara; Dianzani, Umberto; Collino, Massimo
ICOS-Fc, an innovave immune modulator suggested as a new pharmacological strategy in a wide range of pathologies
2024-03-06
ICOSL Stimulation by ICOS‐Fc Accelerates Cutaneous Wound Healing In Vivo
2022-01-01 Stoppa I.; Gigliotti C.L.; Clemente N.; Pantham D.; Dianzani C.; Monge C.; Puricelli C.; Rolla R.; Sutti S.; Reno F.; Boldorini R.; Boggio E.; Dianzani U.
Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment
2021-01-01 Boggio E.; Gigliotti C.L.; Moia R.; Scotta A.; Crespi I.; Boggione P.; De Paoli L.; Deambrogi C.; Garzaro M.; Vidali M.; Chiocchetti A.; Stoppa I.; Rolla R.; Dianzani C.; Monge C.; Clemente N.; Gaidano G.; Dianzani U.
Inducible t-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible t-cell costimulator
2022-01-01 Raineri D.; Cappellano G.; Vilardo B.; Maione F.; Clemente N.; Canciani E.; Boggio E.; Gigliotti C.L.; Monge C.; Dianzani C.; Boldorini R.; Dianzani U.; Chiocchetti A.
Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle
2023-01-01 Azzimonti B.; Ballacchino C.; Zanetta P.; Cucci M.A.; Monge C.; Grattarola M.; Dianzani C.; Barrera G.; Pizzimenti S.
Modulation of the aspartic acid scaffold to identify a new septin-4 covalent binder with anti-metastatic activity in a mouse model of melanoma
2024-01-01 F. Boccato, F. Blua, A. A. Altomare, S. Vittoriob, N. Clemente, C. Monge, E. Marini, M. Bertinaria
Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment
2020-01-01 Dianzani C.; Monge C.; Miglio G.; Serpe L.; Martina K.; Cangemi L.; Ferraris C.; Mioletti S.; Osella S.; Gigliotti C.L.; Boggio E.; Clemente N.; Dianzani U.; Battaglia L.
Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
2023-01-01 Cucci M.A.; Grattarola M.; Monge C.; Roetto A.; Barrera G.; Caputo E.; Dianzani C.; Pizzimenti S.
Nrf2 role in the BRAFi/MEKi acquired resistance in melanoma
2023-01-01 M.A.Cucci, M. Grattarola, C. Monge, A. Roetto, C. Dianzani, S.Pizzimenti
Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies
2021-01-01 Pizzimenti S.; Ribero S.; Cucci M.A.; Grattarola M.; Monge C.; Dianzani C.; Barrera G.; Muzio G.
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment
2022-01-01 Monge, Chiara; Stoppa, Ian; Ferraris, Chiara; Bozza, Annalisa; Battaglia, Luigi; Cangemi, Luigi; Miglio, Gianluca; Pizzimenti, Stefania; Clemente, Nausicaa; Gigliotti, Casimiro Luca; Boggio, Elena; Dianzani, Umberto; Dianzani, Chiara
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Beyond oncological hyperthermia: Physically drivable magnetic nanobubbles as novel multipurpose theranostic carriers in the central nervous system | 2020 | Ficiara E.; Ansari S.A.; Argenziano M.; Cangemi L.; Monge C.; Cavalli R.; D'Agata F. | |
| Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas | 2024 | Dianzani, Chiara; Bozza, Annalisa; Bordano, Valentina; Cangemi, Luigi; Ferraris, Chiara; Foglietta, Federica; Monge, Chiara; Gallicchio, Margherita; Pizzimenti, Stefania; Marini, Elisabetta; Muntoni, Elisabetta; Valsania, Maria Carmen; Battaglia, Luigi | |
| Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma | 2024 | Blua F.; Monge C.; Gastaldi S.; Clemente N.; Pizzimenti S.; Lazzarato L.; Senetta R.; Vittorio S.; Gigliotti C.L.; Boggio E.; Dianzani U.; Vistoli G.; Altomare A.A.; Aldini G.; Dianzani C.; Marini E.; Bertinaria M. | |
| Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications | 2023 | Boggio E.; Gigliotti C.L.; Stoppa I.; Pantham D.; Sacchetti S.; Rolla R.; Grattarola M.; Monge C.; Pizzimenti S.; Dianzani U.; Dianzani C.; Battaglia L. | |
| G protein–coupled receptor 21 in macrophages: An in vitro study | 2022 | Bordano V.; Kinsella G.K.; Cannito S.; Dianzani C.; Gigliotti C.L.; Stephens J.C.; Monge C.; Bocca C.; Rosa A.C.; Miglio G.; Dianzani U.; Findlay J.B.C.; Benetti E. | |
| Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases | 2024 | Bozza, Annalisa; Bordano, Valentina; Marengo, Arianna; Muntoni, Elisabetta; Marini, Elisabetta; Lazzarato, Loretta; Dianzani, Chiara; Monge, Chiara; Rosa, Arianna Carolina; Cangemi, Luigi; Valsania, Maria Carmen; Colitti, Barbara; Camisassa, Ezio; Battaglia, Luigi | |
| ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis | 2022 | Alves, Gustavo Ferreira; Stoppa, Ian; Aimaretti, Eleonora; Monge, Chiara; Mastrocola, Raffaella; Porchietto, Elisa; Einaudi, Giacomo; Collotta, Debora; Bertocchi, Ilaria; Boggio, Elena; Gigliotti, Casimiro Luca; Clemente, Nausicaa; Aragno, Manuela; Fernandes, Daniel; Cifani, Carlo; Thiemermann, Christoph; Dianzani, Chiara; Dianzani, Umberto; Collino, Massimo | |
| ICOS-Fc, an innovave immune modulator suggested as a new pharmacological strategy in a wide range of pathologies | 2024 | - | |
| ICOSL Stimulation by ICOS‐Fc Accelerates Cutaneous Wound Healing In Vivo | 2022 | Stoppa I.; Gigliotti C.L.; Clemente N.; Pantham D.; Dianzani C.; Monge C.; Puricelli C.; Rolla R.; Sutti S.; Reno F.; Boldorini R.; Boggio E.; Dianzani U. | |
| Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment | 2021 | Boggio E.; Gigliotti C.L.; Moia R.; Scotta A.; Crespi I.; Boggione P.; De Paoli L.; Deambrogi C.; Garzaro M.; Vidali M.; Chiocchetti A.; Stoppa I.; Rolla R.; Dianzani C.; Monge C.; Clemente N.; Gaidano G.; Dianzani U. | |
| Inducible t-cell costimulator ligand plays a dual role in melanoma metastasis upon binding to osteopontin or inducible t-cell costimulator | 2022 | Raineri D.; Cappellano G.; Vilardo B.; Maione F.; Clemente N.; Canciani E.; Boggio E.; Gigliotti C.L.; Monge C.; Dianzani C.; Boldorini R.; Dianzani U.; Chiocchetti A. | |
| Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle | 2023 | Azzimonti B.; Ballacchino C.; Zanetta P.; Cucci M.A.; Monge C.; Grattarola M.; Dianzani C.; Barrera G.; Pizzimenti S. | |
| Modulation of the aspartic acid scaffold to identify a new septin-4 covalent binder with anti-metastatic activity in a mouse model of melanoma | 2024 | F. Boccato, F. Blua, A. A. Altomare, S. Vittoriob, N. Clemente, C. Monge, E. Marini, M. Bertinaria | |
| Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment | 2020 | Dianzani C.; Monge C.; Miglio G.; Serpe L.; Martina K.; Cangemi L.; Ferraris C.; Mioletti S.; Osella S.; Gigliotti C.L.; Boggio E.; Clemente N.; Dianzani U.; Battaglia L. | |
| Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma | 2023 | Cucci M.A.; Grattarola M.; Monge C.; Roetto A.; Barrera G.; Caputo E.; Dianzani C.; Pizzimenti S. | |
| Nrf2 role in the BRAFi/MEKi acquired resistance in melanoma | 2023 | M.A.Cucci, M. Grattarola, C. Monge, A. Roetto, C. Dianzani, S.Pizzimenti | |
| Oxidative stress-related mechanisms in melanoma and in the acquired resistance to targeted therapies | 2021 | Pizzimenti S.; Ribero S.; Cucci M.A.; Grattarola M.; Monge C.; Dianzani C.; Barrera G.; Muzio G. | |
| Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment | 2022 | Monge, Chiara; Stoppa, Ian; Ferraris, Chiara; Bozza, Annalisa; Battaglia, Luigi; Cangemi, Luigi; Miglio, Gianluca; Pizzimenti, Stefania; Clemente, Nausicaa; Gigliotti, Casimiro Luca; Boggio, Elena; Dianzani, Umberto; Dianzani, Chiara |